Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in improved adverse effects including drowsiness, Even though the scientific relevance is reduced in many patients – monitor the client for adverse effects (e.If affected person are unable to resume their usual o